The MAPK/ERK signaling pathway is an additional crucial target for inhibitors. Inhibitors targeting MAPK/ERK are used in cancer cells treatments to prevent unrestrained cell spreading and lump development.Anti-infection inhibitors incorporate a broader array of agents that target various virus such as bloodsuckers, fungi, and viruses. In the world